Skip to main content

Home/ science/ Group items tagged tumors:

Rss Feed Group items tagged

Erich Feldmeier

Cory Abate-Shen: A Molecular Signature Predictive of Indolent Prostate Cancer - 0 views

  •  
    Many newly diagnosed prostate cancers present as low Gleason score tumors that require no treatment intervention. Distinguishing the many indolent tumors from the minority of lethal ones remains a major clinical challenge. We now show that low Gleason score prostate tumors can be distinguished as indolent and aggressive subgroups on the basis of their expression of genes associated with aging and senescence. Using gene set enrichment analysis, we identified a 19-gene signature enriched in indolent prostate tumors. We then further classified this signature with a decision tree learning model to identify three genes-FGFR1, PMP22, and CDKN1A-that together accurately predicted outcome of low Gleason score tumors. Validation of this three-gene panel on independent cohorts confirmed its independent prognostic value as well as its ability to improve prognosis with currently used clinical nomograms. Furthermore, protein expression of this three-gene panel in biopsy samples distinguished Gleason 6 patients who failed surveillance over a 10-year period. We propose that this signature may be incorporated into prognostic assays for monitoring patients on active surveillance to facilitate appropriate courses of treatment.
anonymous

How Dangerous Is Brain Cancer? - 0 views

  •  
    Tumors causing brain cancer are usually formed in human brains, and this kind is largely called primary tumors. But sometimes tumors formed in some other parts of the body are carried to the brain and are popularly known as metastatic tumors.
Erich Feldmeier

Reiner Hartenstein: Werden Tumore Krebs Cancer durch Angiogenese-Hemmer aggressiver? (A... - 0 views

  •  
    dass bei Mäusen mindestens 2 der 3 zur Krebstherapie zugelassenen Angiogenese-Hemmer die Bösartigkeit von Tumoren erhöhen können (Cancer Cell 2009, Band 15: Seite 220 und 232). Wurden krebskranke Labortiere mit den Wirkstoffen Sunitinib oder Sorafenib behandelt, verlangsamte sich einerseits das Tumorwachstum deutlich, andererseits drangen die Tumore verstärkt in das umliegende Gewebe ein und bildeten mehr Metastasen. .. Offenbar verlangsamen Angiogenese-Hemmer zunächst das Wachstum eines Tumors, bis dieser auf das knappe Nährstoffangebot reagiert und sich gegen das Aushungern zur Wehr setzt. „Möglicherweise liegt das daran, dass ein Tumor sein Wachstumsverhalten ändert, wenn er nicht mehr ausreichend versorgt wird. Indem er in benachbartes Gewebe eindringt und Tochtergeschwülste bildet, könnte er versuchen, wieder mehr Nachschub zu bekommen
stevencd

Oral Tumor Cells - 0 views

  •  
    Creative Bioarray provides various human and animal cell lines that are invaluable for medical, scientific and pharmaceutical institutions. Creative Bioarray offers Oral Tumor Cells for your research.
stevencd

Kidney Tumor Cells - 0 views

  •  
    Creative Bioarray provides various human and animal cell lines that are invaluable for medical, scientific and pharmaceutical institutions. Creative Bioarray offers Kidney Tumor Cells for your research.
stevencd

Ovarian Tumor Cells - 0 views

  •  
    Creative Bioarray provides various human and animal cell lines that are invaluable for medical, scientific and pharmaceutical institutions. Creative Bioarray offers Ovarian Tumor Cells for your research.
stevencd

Testicular Tumor Cells - 0 views

  •  
    Creative Bioarray provides various human and animal cell lines that are invaluable for medical, scientific and pharmaceutical institutions. Creative Bioarray offers Testicular Tumor Cells for your research.
thinkahol *

Blood-vessel cells can combat aggressive tumors: MIT scientists | KurzweilAI - 3 views

  •  
    MIT scientists have discovered that endothelial cells, which line the blood vessels, secrete molecules that suppress tumor growth and keep cancer cells from invading other tissues, a finding that could lead to a new way to treat cancer.
Charles Daney

Experimental Drug Shows Promise for Several Cancers -- ScienceNOW - 0 views

  •  
    In the first clinical proof of its kind, a drug has dramatically shrunk cancerous tumors by disrupting a key genetic pathway. But a study targeting one deadly brain cancer, medulloblastoma, ended in disappointment as the patient's once-tamed tumor quickly developed resistance to the drug and killed him.
Charles Daney

Tumor suppressor pulls double shift as reprogramming watchdog - 0 views

  •  
    A collaborative study by researchers at the Salk Institute for Biological Studies uncovered that the tumor suppressor p53 not only stops cells that could become cancerous in their tracks but also controls somatic cell reprogramming.
anonymous

All About Brain Cancer - 0 views

  •  
    The dreadful disease brain cancer affects the part of the brain cell and slowly spreads to the whole part and turns to be a deadly tumor. Due to this the individual who falls as a prey to the disease will face several health issues while fighting with the destructive cell.
anonymous

Symptoms of Brain Tumors - 0 views

  •  
    Brain tumors are surely frightening but apart from all these painful ways, a brain cancer patient can simply try out the Energy Transmission by Trivedi Masters™.
anonymous

Brain Tumor and Brain Cancer - 0 views

  •  
    Brain tumor and brain cancer are synonymous terms. Due to the formation of abnormal cells in the human brain this disease occurs. Human beings below the age of 40 years, especially the kids are the most affected ones by this particular sort of cancer.
anonymous

Researches In Medical Field In India - 1 views

India has made quite a progress in the medical field in the past few decades. The advanced technologies and regular efforts made by medical professionals, be it physicians or Ph.D's, has only led u...

Stem cell research research in material science' stem cell cancer research' Trivedi Effect Trivedi Science

started by anonymous on 23 Feb 15 no follow-up yet
Erich Feldmeier

Douglas Hanahan: CiteULike: The Hallmarks of Cancer, Krebs - 0 views

  •  
    "The SOS-Ras-Raf-MAPK cascade plays a central role here. In about 25% of human tumors, Ras proteins are present in structurally altered forms that enable them to release a flux of mitogenic signals into cells, without ongoing stimulation by their normal upstream regulators (Medema and Bos 1993). We suspect that growth signaling pathways suffer deregulation in all"
Erich Feldmeier

wissenschaft.de - Lebensrettende Hybrid-Organe aus dem Labor - 0 views

  •  
    "Die Forscher erzeugten sie aus einem synthetischen Gerüst, bestückt mit Stammzellen aus dem Knochenmark des Patienten. Die Besiedelung mit eigenen Stammzellen soll dabei ein lebendiges Gewebe ermöglichen und gleichzeitig verhindern, dass das Organ vom Immunsystem abgestoßen wird. In einem speziellen Bioreaktor wurde das Gerüstmaterial mit einer stammzellhaltigen Flüssigkeit 36 Stunden lang benetzt. Die Zellen setzten sich dabei in die Poren des Trägermaterials und wuchsen ineinander. Das fertige Hybrid-Organ verpflanzten die Forscher dann nach Entfernung des Tumors in einer zwölfstündigen Operation. In der Luftröhre haben sich mittlerweile neue Blutgefäße gebildet, was dafür spreche, dass die Stammzellen langfristig angewachsen seien"
Erich Feldmeier

Siegfried Weiß: Schaltbare Salmonellen im Kampf gegen Krebs - bild der wissen... - 0 views

  •  
    "nun ist es deutschen Wissenschaftlern gelungen, Salmonellen so zu verändern, dass sie zunächst Tumore angreifen, sich anschließend jedoch dem Immunsystem ergeben. Trotz großer Fortschritte ist Krebs immer noch die zweithäufigste Todesursache in der westlichen Welt. Neue Ideen für Therapieformen sind deshalb gefragt. Bakterienvermittelte Tumortherapie, so nennt sich in diesem Zusammenhang das Forschungsziel der Wissenschaftler vom Helmholtz-Zentrum"
stevencd

Stem Cells - 0 views

  •  
    Creative Bioarray offers over 1000 stem cell products including adult stem cells, tumor stem cells, embryonic stem cells, iPS cells and other stem cells.
Skeptical Debunker

Human cells exhibit foraging behavior like amoebae and bacteria - 0 views

  • "As far as we can tell, this is the first time this type of behavior has been reported in cells that are part of a larger organism," says Peter T. Cummings, John R. Hall Professor of Chemical Engineering, who directed the study that is described in the March 10 issue of the Public Library of Science journal PLoS ONE. The discovery was the unanticipated result of a study the Cummings group conducted to test the hypothesis that the freedom with which different cancer cells move - a concept called motility - could be correlated with their aggressiveness: That is, the faster a given type of cancer cell can move through the body the more aggressive it is. "Our results refute that hypothesis—the correlation between motility and aggressiveness that we found among three different types of cancer cells was very weak," Cummings says. "In the process, however, we began noticing that the cell movements were unexpectedly complicated." Then the researchers' interest was piqued by a paper that appeared in the February 2008 issue of the journal Nature titled, "Scaling laws of marine predator search behaviour." The paper contained an analysis of the movements of a variety of radio-tagged marine predators, including sharks, sea turtles and penguins. The authors found that the predators used a foraging strategy very close to a specialized random walk pattern, called a Lévy walk, an optimal method for searching complex landscapes. At the end of the paper's abstract they wrote, "...Lévy-like behaviour seems to be widespread among diverse organisms, from microbes to humans, as a 'rule' that evolved in response to patchy resource distributions." This gave Cummings and his colleagues a new perspective on the cell movements that they were observing in the microscope. They adopted the basic assumption that when mammalian cells migrate they face problems, such as efficiently finding randomly distributed targets like nutrients and growth factors, that are analogous to those faced by single-celled organisms foraging for food. With this perspective in mind, Alka Potdar, now a post-doctoral fellow at Case Western Reserve University and the Cleveland Clinic, cultured cells from three human mammary epithelial cell lines on two-dimensional plastic plates and tracked the cell motions for two-hour periods in a "random migration" environment free of any directional chemical signals. Epithelial cells are found throughout the body lining organs and covering external surfaces. They move relatively slowly, at about a micron per minute which corresponds to two thousandths of an inch per hour. When Potdar carefully analyzed these cell movements, she found that they all followed the same pattern. However, it was not the Lévy walk that they expected, but a closely related search pattern called a bimodal correlated random walk (BCRW). This is a two-phase movement: a run phase in which the cell travels primarily in one direction and a re-orientation phase in which it stays in place and reorganizes itself internally to move in a new direction. In subsequent studies, currently in press, the researchers have found that several other cell types (social amoeba, neutrophils, fibrosarcoma) also follow the same pattern in random migration conditions. They have also found that the cells continue to follow this same basic pattern when a directional chemical signal is added, but the length of their runs are varied and the range of directions they follow are narrowed giving them a net movement in the direction indicated by the signal.
  •  
    When cells move about in the body, they follow a complex pattern similar to that which amoebae and bacteria use when searching for food, a team of Vanderbilt researchers have found. The discovery has a practical value for drug development: Incorporating this basic behavior into computer simulations of biological processes that involve cell migration, such as embryo development, bone remodeling, wound healing, infection and tumor growth, should improve the accuracy with which these models can predict the effectiveness of untested therapies for related disorders, the researchers say.
Walid Damouny

Freezing out breast cancer - 0 views

  •  
    "Interventional radiologists have opened the door to an encouraging potential future treatment for the nearly 200,000 women who are diagnosed with breast cancer in the United States each year: image-guided, multiprobe cryotherapy. In the first reported study, researchers were able to successfully freeze breast cancer in patients who refused surgery; the women did not have to undergo surgery after treatment to ensure that tumors had been killed, note researchers at the Society of Interventional Radiology's 35th Annual Scientific Meeting in Tampa, Fla."
1 - 20 of 29 Next ›
Showing 20 items per page